COMMUNIQUÉS West-GlobeNewswire

-
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
17/07/2025 -
Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum - Crafted for Everyone Who Loves a Great Drink
17/07/2025 -
Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture
17/07/2025 -
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
17/07/2025 -
Velocity Clinical Research Partners with Palantir to Solve Clinical Trials’ Payment Headache
17/07/2025 -
Repligen to Report Second Quarter 2025 Financial Results
17/07/2025 -
Peptides For Muscle Growth: How Oral Legal Peptides by Crazy Bulk Set New Benchmark For Bodybuilding Supplements and Muscle Building Results
17/07/2025 -
KFSHRC Performs World’s First Robotic-Assisted BiVAD Implantation
17/07/2025 -
Keros Therapeutics Announces the First Patient Dosing in the Phase 3 RENEW Clinical Trial of Elritercept
17/07/2025 -
BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting
17/07/2025 -
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies
17/07/2025 -
Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition
17/07/2025 -
INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
17/07/2025 -
Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025
17/07/2025 -
Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update
17/07/2025 -
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria
17/07/2025 -
Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships
17/07/2025 -
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
17/07/2025 -
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
17/07/2025
Pages